Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK8 | P49336 | 4/20 | 0.51 |
| ▸ | CCNC | P24863 | 3/20 | 0.51 |
| ▸ | GAK | O14976 | 2/20 | 0.49 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.49 |
| ▸ | COQ8A | Q8NI60 | 2/20 | 0.49 |
| ▸ | NLK | Q9UBE8 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.47 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.45 |
| ▸ | PDE5A | O76074 | 1/20 | 0.43 |
| ▸ | CDK19 | Q9BWU1 | 2/20 | 0.42 |
| ▸ | CDKN1A | P38936 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL983082 | 0.98 | CDK8 (0.50) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL16289311 | 0.82 | SMN1; SMN2 (0.47) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL16288743 | 0.79 | SMN1; SMN2 (0.49) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL24010750 | 0.79 | GAK (0.64) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL29843629 | 0.79 | SLC22A12 (0.51) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL29843782 | 0.79 | CDK8 (0.48) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL23625624 | 0.79 | CDK8 (0.48) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL730084 | 0.79 | PDE5A (0.49) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL633785 | 0.79 | CDK8 (0.48) | CDK8CCNCGAKRIPK2COQ8A | |
| SCHEMBL30369707 | 0.79 | PDE5A (0.49) | CDK8CCNCGAKRIPK2COQ8A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220089600-A1 | TGFß INHIBITOR AND PRODRUGS | FUNDACIÓ INSTITUT DE RECERCA BIOMÈDICA (IRB BARCELONA) (ES) | 2022-03-24 | — | — | US | disclosed |
| EP-2952096-B1 | Amide compound, an arthropod pest control agent and a method for controlling arthropod pest | SUMITOMO CHEMICAL CO (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-9814235-B2 | Method for controlling arthropod pest | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-14 | — | — | US | disclosed |
| EP-2952096-A1 | METHOD FOR CONTROLLING ARTHROPOD PEST | Sumitomo Chemical Company, Limited (JP) | 2015-12-09 | — | — | EP | disclosed |
| US-20150344466-A1 | METHOD FOR CONTROLLING ARTHROPOD PEST | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-03 | — | — | US | disclosed |
| EP-1910370-B1 | A PYRIDIN QUINOLIN SUBSTITUTED PYRROLO [1,2-B] PYRAZOLE MONOHYDRATE AS TGF-BETA INHIBITOR | LILLY CO ELI (US) | 2015-04-22 | — | — | EP | disclosed |
| EP-1910370-B1 | A PYRIDIN QUINOLIN SUBSTITUTED PYRROLO [1,2-B] PYRAZOLE MONOHYDRATE AS TGF-BETA INHIBITOR | LILLY CO ELI (US) | 2015-04-22 | — | — | EP | disclosed |
| US-20150005348-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-01-01 | — | — | US | disclosed |
| EP-2813492-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | Sumitomo Chemical Co., Ltd (JP) | 2014-12-17 | — | — | EP | disclosed |
| CN-102015678-A | Fused pyridine active substances as c-Met inhibitors | HOFFMANN LA ROCHE | 2011-04-13 | — | — | CN | disclosed |
| US-20110053935-A1 | FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET | F. HOFFMANN-LA ROCHE AG (CH) | 2011-03-03 | — | — | US | disclosed |
| US-7872020-B2 | TGF-β inhibitors | ELI LILLY AND COMPANY (US) | 2011-01-18 | — | — | US | disclosed |
| US-7872020-B2 | TGF-β inhibitors | ELI LILLY AND COMPANY (US) | 2011-01-18 | — | — | US | disclosed |
| EP-2247584-A1 | FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET | F. Hoffmann-La Roche AG (CH) | 2010-11-10 | — | — | EP | disclosed |
| US-20100120854-A1 | TGF-BETA INHIBITORS | ELI LILLY AND COMPANY (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100120854-A1 | TGF-BETA INHIBITORS | ELI LILLY AND COMPANY (US) | 2010-05-13 | — | — | US | disclosed |
| WO-2009093049-A1 | FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET | F. HOFFMANN-LA ROCHE AG (CH) | 2009-07-30 | — | — | WO | disclosed |
| EP-1910370-A1 | A PYRIDIN QUINOLIN SUBSTITUTED PYRROLO [1,2-B] PYRAZOLE MONOHYDRATE AS TGF-BETA INHIBITOR | ELI LILLY AND COMPANY (US) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007018818-A1 | A PYRIDIN QUINOLIN SUBSTITUTED PYRROLO [1,2-B] PYRAZOLE MONOHYDRATE AS TGF-BETA INHIBITOR | ELI LILLY AND COMPANY (US) | 2007-02-15 | — | — | WO | disclosed |
| WO-2007018818-A1 | A PYRIDIN QUINOLIN SUBSTITUTED PYRROLO [1,2-B] PYRAZOLE MONOHYDRATE AS TGF-BETA INHIBITOR | ELI LILLY AND COMPANY (US) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089600-A1 | TGFß INHIBITOR AND PRODRUGS | TGFB1, TGFBR1, TGFBR2 | CDK8 1517/4885CCNC 2710/4885GAK 2159/4885 |
| US-20150344466-A1 | METHOD FOR CONTROLLING ARTHROPOD PEST | H1-0, H1-3, H1-2 | CDK8 3738/4885CCNC 2881/4885GAK 2512/4885 |
| US-20150005348-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | RPS8, MT-CO2, ARG1 | CDK8 1061/4885CCNC 2113/4885GAK 2304/4885 |
| US-20110053935-A1 | FUSED PYRIDINES ACTIVE AS INHIBITORS OF C-MET | MET, ROS1, ABL1 | CDK8 658/4885CCNC 945/4885GAK 627/4885 |
| US-20100120854-A1 | TGF-BETA INHIBITORS | TGFBR1, TGFBR2, SMAD3 | CDK8 1126/4885CCNC 1738/4885GAK 2143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.